254
Views
0
CrossRef citations to date
0
Altmetric
Editorial

New Agents to Treat Lung Infection in Cystic Fibrosis: A Big Enough Leap?

&
Pages 117-120 | Published online: 30 Jan 2013
 

Financial & competing interests disclosure

M Hurley is funded by the Wellcome Trust by way of a Clinical Research Training Fellowship. A Smyth sits on a trial steering committee for REMPEX Pharma, advisory boards for Forest Labs and Vertex and has given a paid lecture for Gilead. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

M Hurley is funded by the Wellcome Trust by way of a Clinical Research Training Fellowship. A Smyth sits on a trial steering committee for REMPEX Pharma, advisory boards for Forest Labs and Vertex and has given a paid lecture for Gilead. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.